Combined Holdings of Vertex Pharmaceuticals (VRTX) - Updated Daily
TherapeuticsGene TherapyGenomicsCRSPR Gene Editing
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
0.31% | $101.70b |
🏋️♀️Weight Rank Across All Funds | 🌏Country |
52 | 🇺🇸United States |
💳ARK Estimated Cost Average | 🎫ARK Ownership Percent |
$225.49 - ARKG | 0.03% |
Other ETFs That Hold VRTX
Research Notes and Commentary for VRTX
No Research Notes Found for VRTX